Finance

A longtime market bull sees an under-the-radar trend that should calm runaway inflation fears, and it has nothing to do with Federal Reserve policy. According to The Leuthold Group’s Jim Paulsen, private money coming from individuals and companies has been acting as a “very encouraging” market mechanism to help curb inflation. “We make decisions about
0 Comments
Wilmington Trust’s Meghan Shue is opening her playbook for the year’s second half — which starts Thursday. Her strategy includes an overexposure to cyclicals, and she favors financials, energy, commodities, materials and industrials. “We see the economic recovery continuing and being a tailwind for stocks,” the firm’s head of investment strategy told CNBC’s “Trading Nation”
0 Comments
Federal Reserve Vice Chairman for Supervision Randal Quarles addresses the Economic Club of New York in New York City, October 18, 2018. Brendan McDermid | Reuters The Federal Reserve announced Thursday that the biggest U.S. banks could easily withstand a severe recession, a milestone for the once-beleaguered industry. The Fed, in releasing the results of
0 Comments
In this article SPCX Andreessen Horowitz partner Marc Andreessen Justin Sullivan | Getty Images Andreessen Horowitz is launching a multibillion-dollar fund to invest in a volatile ecosystem it’s betting will be as influential as the internet. The Silicon Valley venture capital firm, founded by Marc Andreessen and Ben Horowitz, announced its new $2.2 billion cryptocurrency-focused
0 Comments
He predicted tech’s recent comeback, and now Oppenheimer Asset Management’s John Stoltzfus believes Wall Street can avoid an unnerving summer setback. He attributes tech’s latest outperformance as a key reason why it could be a positive summer for investors. “That might be possible,” the firm’s chief investment strategist told CNBC’s “Trading Nation” on Wednesday. “Fundamentals
0 Comments
Take a look at some of the biggest movers in the premarket: GlaxoSmithKline (GSK) – The drugmaker’s stock rose 3.5% in the premarket after it detailed plans to spin out its consumer health-care business into a separate company. Glaxo will eventually receive an $11 billion payment from the new company. MicroStrategy (MSTR) – MicroStrategy rallied
0 Comments